These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 18161048)
1. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Nishida N; Nagasaka T; Nishimura T; Ikai I; Boland CR; Goel A Hepatology; 2008 Mar; 47(3):908-18. PubMed ID: 18161048 [TBL] [Abstract][Full Text] [Related]
2. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
3. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. Um TH; Kim H; Oh BK; Kim MS; Kim KS; Jung G; Park YN J Hepatol; 2011 May; 54(5):939-47. PubMed ID: 21145824 [TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis virus infection affects DNA methylation in mice with humanized livers. Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133 [TBL] [Abstract][Full Text] [Related]
6. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection. Narimatsu T; Tamori A; Koh N; Kubo S; Hirohashi K; Yano Y; Arakawa T; Otani S; Nishiguchi S Intervirology; 2004; 47(1):26-31. PubMed ID: 15044833 [TBL] [Abstract][Full Text] [Related]
7. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893 [TBL] [Abstract][Full Text] [Related]
8. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390 [TBL] [Abstract][Full Text] [Related]
9. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India. Kiran M; Chawla YK; Kaur J Cancer Genet Cytogenet; 2009 Dec; 195(2):112-9. PubMed ID: 19963110 [TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368 [TBL] [Abstract][Full Text] [Related]
11. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Yang B; Guo M; Herman JG; Clark DP Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151 [TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis virus and aging on DNA methylation in human hepatocarcinogenesis. Nishida N Histol Histopathol; 2010 May; 25(5):647-54. PubMed ID: 20238302 [TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. Lambert MP; Paliwal A; Vaissière T; Chemin I; Zoulim F; Tommasino M; Hainaut P; Sylla B; Scoazec JY; Tost J; Herceg Z J Hepatol; 2011 Apr; 54(4):705-15. PubMed ID: 21146512 [TBL] [Abstract][Full Text] [Related]
14. Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status. Song MA; Kwee SA; Tiirikainen M; Hernandez BY; Okimoto G; Tsai NC; Wong LL; Yu H Epigenetics; 2016 Jun; 11(6):464-74. PubMed ID: 27248055 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma. Formeister EJ; Tsuchiya M; Fujii H; Shpyleva S; Pogribny IP; Rusyn I Mutat Res; 2010 Oct; 692(1-2):26-33. PubMed ID: 20736025 [TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822 [TBL] [Abstract][Full Text] [Related]
17. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China. Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501 [TBL] [Abstract][Full Text] [Related]
18. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
19. Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma. Deng YB; Nagae G; Midorikawa Y; Yagi K; Tsutsumi S; Yamamoto S; Hasegawa K; Kokudo N; Aburatani H; Kaneda A Cancer Sci; 2010 Jun; 101(6):1501-10. PubMed ID: 20345479 [TBL] [Abstract][Full Text] [Related]
20. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Huang J; Wang Y; Guo Y; Sun S Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]